Saturday, December 9, 2023
This activity is intended for cardiologists, critical care clinicians, neurologists, family medicine and primary care clinicians, nurses, nurse practitioners, internists, physician assistants, and other members of the health care team who treat and manage patients with stroke.
The goal of this activity is for learners to be better able to describe the association of complicated carotid artery plaque ipsilateral to acute ischemic anterior circulation stroke with recurrent ischemic stroke or transient ischemic attack, based on the CAPIAS (Carotid Plaque Imaging in Acute Stroke) multicenter study by Kopczak and colleagues.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 7/08/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 7/8/2022
Valid for credit through: 7/8/2023, 11:59 PM EST
processing....
Stroke is a leading cause of death, disability, and cognitive decline. Recurrence rates vary depending on stroke etiology.
In patients with symptomatic carotid artery stenosis, high-risk features of carotid artery plaque, particularly intraplaque hemorrhage, on magnetic resonance imaging (MRI) have been linked to increased risk for recurrent ischemic stroke or transient ischemic attack (TIA). Because of study limitations, however, risks associated with complicated carotid artery plaques in the acute phase of stroke are still unknown.
Small but vulnerable carotid plaques appear to be a more important cause of stroke than previously thought, a new study suggests.
Results of the Carotid Plaque Imaging in Acute Stroke (CAPIAS) study show that patients with complicated carotid artery plaques ipsilateral to acute ischemic anterior circulation stroke had an increased risk for recurrent ischemic stroke.
"This study found ipsilateral [complicated carotid artery plaques] as detected by high-resolution MRI within 10 days from ischemic stroke onset to be associated with a higher risk of recurrent ischemic stroke or TIA. The results were driven by the results in cryptogenic stroke patients and by events ipsilateral to the index stroke," the authors report.
"Carotid plaque imaging identifies high-risk patients who might be suited for inclusion into future secondary prevention trials," they conclude.
The study, led by Anna Kopczak, MD, from the University Hospital, LMU Munich, is published in the June 7 issue of the Journal of the American College of Cardiology.[1]
In an accompanying editorial, Joshua Z. Willey, MD, and Gerard Pasterkamp, MD, say the study "highlights the importance of considering substenotic atherosclerotic plaques as a cause of ischemic stroke and the subsequent risk of recurrence, and it broadens our understanding of the concept of [embolic stroke of undetermined source]."[2]
Dr Willey explained that about 30% of patients with stroke have an embolic stroke of undermined source, and although there is quite a good understanding of cardiac sources of embolic stroke, this study suggests that carotid plaques could be contributing more than previously thought to these types of strokes.
Dr Willey also noted that at present, only patients with carotid stenosis greater than 50% are considered for surgery or more aggressive treatment.
"This study has done a very nice job showing that smaller plaques can be a source of stroke; members of the health care team must be aware that patients with these smaller but vulnerable plaques may need to be considered for more tests and secondary preventative treatments," he added.
Recurrent Events
The CAPIAS study prospectively recruited patients in the 10 days after an ischemic stroke restricted to the territory of a single carotid artery who underwent multisequence, contrast-enhanced MRI to identify complicated carotid artery plaques. These were defined by the presence of a ruptured fibrous cap, intraplaque hemorrhage, or mural thrombus.
Among 196 patients enrolled, 104 were found to have had a cryptogenic stroke and had smaller nonstenosing carotid artery plaques.
Recurrent events were significantly more frequent in patients with complicated carotid artery plaques than in those without such plaques, both in the overall cohort (incidence rate, 9.50 vs 3.61 per 100 patient-years) and in patients with cryptogenic stroke (10.92 vs 1.82 per 100 patient-years). The results were driven by ipsilateral events.
Among patients with cryptogenic stroke, those with ipsilateral complicated carotid artery plaques had a 5.6-fold increased risk for recurrent ischemic stroke or TIA compared with those without such plaques, the authors report, with the presence of an ipsilateral ruptured fibrous cap and of intraplaque hemorrhage significantly associated with recurrent ischemic stroke or TIA.
The researchers say that the most important finding in terms of clinical implications in the study is the association between intraplaque hemorrhage and an increased risk for recurrent ischemic stroke or TIA in patients with cryptogenic stroke.
They point out that unlike other features of complicated carotid artery plaques, intraplaque hemorrhage can be reliably detected by standard coils and conventional native T1-weighted sequences, indicating that MRI for intraplaque hemorrhage detection could be integrated into the diagnostic workflow of anterior circulation stroke.
They suggest that the next step should be a multicenter study to determine the precise prevalence of intraplaque hemorrhage and associated recurrence rates in unselected patients with anterior circulation stroke.
"At present, there is a perception that if the carotid plaque is causing less than a 50% stenosis, then this is not directly related to the stroke," Dr Willey commented. "But this study shows this not to be the case and that we need to think more carefully about patients with smaller carotid plaques. This study showed that vulnerable carotid plaques are particularly dangerous, and at the moment, these plaques are not being identified and treated.
"This opens up a new group of patients for whom more aggressive secondary preventative therapy may be required. This observation makes sense, as it parallels what we know about coronary disease," he added.
Dr Willey noted that this study raises the issue of whether patients with smaller carotid plaques could benefit from more advanced imaging to identify those with vulnerable plaques, but he pointed out that the study needs to be replicated in a more diverse population of patients to better understand the degree to which this affects different groups.
He explained that the proportion of embolic strokes of unknown source that will originate from vulnerable carotid plaques is hard to define and will vary between different populations.
"Older patients are more likely to have a stroke caused by undiagnosed [atrial fibrillation]. But patients with a high burden of risk factors, such as smoking, diabetes, or high cholesterol, are more likely to have vulnerable plaque. I suspect rates of vulnerable carotid plaques among [embolic stroke of undetermined source] patients could be around 30% or more in these types of patients," Dr Willey said.
